BIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, and Belgium-based AARDEX GROUP, the leader in tools for measuring and managing adherence to medication in clinical trials are proud to announce one of their first major joint initiatives that will come live in the upcoming months.
> En savoir plusBIOCORP, a French company specialized in the design, development, and manufacturing of innovative medical devices, today announces an agreement with Novo Nordisk, a world leader in diabetes care, for the development and distribution (pending successful development) of a Mallya smart add-on device for the Novo Nordisk FlexTouch pen used by people with diabetes.
By combining their key technologies, both companies offer innovative specific solutions for clinical trials and numerous commercial applications.
> En savoir plusThanks to the partnership signed with Roche Diabetes Care France, Mallya will soon be available for purchase in pharmacies in France. More info coming soon!
> En savoir plusThe leader in self-monitoring of blood glucose in France will distribute Mallya connected device to pharmacists and will integrate it into its Roche Diabetes digital ecosystem.
> En savoir plusBIOCORP and Thea Laboratories are joining forces to design, develop and manufacture connected medical devices to help patients suffering from blinding diseases such as glaucoma.
> En savoir plus
